MNKI-8e
CAS No. 1610886-04-8
MNKI-8e( MNK inhibitor 8e )
Catalog No. M12328 CAS No. 1610886-04-8
MNKI-8e (MNK inhibitor 8e) is a potent, selective MNK inhibitor that inhibits Mnk2 with Ki of 0.37 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMNKI-8e
-
NoteResearch use only, not for human use.
-
Brief DescriptionMNKI-8e (MNK inhibitor 8e) is a potent, selective MNK inhibitor that inhibits Mnk2 with Ki of 0.37 uM.
-
DescriptionMNKI-8e (MNK inhibitor 8e) is a potent, selective MNK inhibitor that inhibits Mnk2 with Ki of 0.37 uM, displays >34-fold and 4-fold over CDK2 (Ki>10 uM) and CDK9 (Ki=1.66 uM); potently inhibits leukemia cells with GI50 of 1.23-7.36 uM (MV4-11 GI50=1.32 uM and KG-1 GI50=1.23 uM); blocks phosphorylation of eIF4E, downregulates anti-apoptotic protein Mcl-1 and induces apoptosis in AML cells; suppresses the Ara-C-induced MAPK activity and enhances apoptosis in MV4-11 cells.
-
In Vitro——
-
In Vivo——
-
SynonymsMNK inhibitor 8e
-
PathwayMAPK/ERK Signaling
-
TargetMNK
-
RecptorMNK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1610886-04-8
-
Formula Weight358.416
-
Molecular FormulaC17H18N4O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name5-(2-((2,4-dimethoxyphenyl)amino)pyrimidin-4-yl)-3,4-dimethylthiazol-2(3H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Diab S, et al. ChemMedChem. 2014 May;9(5):962-72.
2. Li P, et al. Oncotarget. 2016 Aug 30;7(35):56811-56825.
molnova catalog
related products
-
MNK-IN-54
MNK-IN-54 is a potent, orally bioavailable dual MNK1/2 and BCR-ABL1 inhibitor.
-
DS12881479
DS12881479 can be used in cancer research which is a potent and selective inhibitor of Mnk1(IC 50 =21 nM) .
-
MNK inhibitor 9
MNK inhibitor 9 is a potent, selective MAPK-interacting kinase (MNK1 and MNK2) inhibitor with IC50 of 3 nM for both, with no activity aginst CDK1/2 (IC50>25 uM).
Cart
sales@molnova.com